Next-day memory impairment triazolam prevalence rate degree memory impairment next-day activities short intermittent course bedtime doses triazolam temazepam placebo double-blind parallel-group study subjects triazolam group episode next-day memory impairment/amnesia total episodes subject-drug nights rate temazepam group episodes memory impairment Immediate recall active drug placebo night Impairment delayed recall several times temazepam placebo groups Next-day memory impairment/amnesia bedtime dose triazolam continued intermittent drug use Cognitive impairments triazolam spectrum organic brain dysfunction memory impairment/amnesia confusion commonest milder manifestations hallucinations delusions severe common features 